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Summary - The synthesis of the diastereomeric 1,2-bis(2-,3- and 4-fluorophenyl)ethylenediamines 4-6, lo-12 from 
meso-1,2-bis(2-hydroxyphenyl)ethylenediamine and 2-, 3- and 4-fluorobenzaldehyde by a diaza-Cope-rearrangement 
and their conversion into the [1,2-bis(2-, 3- and 4-fluorophenyl)ethylenediamine]dihaloplatinum (II) complexes (Hal 
= Cl, 13-M; Hal = I, 19-24) with K,PtHal, is described. From the diiodoplatinum(I1) complexes (19-24) the better 
water soluble diaqua[l,Zbis(2-, 3- and 4-fluorophenyl)ethylenediamine]platinum(II) sulfates (25-30) and [1,2-bis(4- 
fluorophenyl)ethylenediamine]dinitratoplatinum (II) complexes (31 and 32) are obtained by reacting with Ag2S04 or 
AgNOs. On the P388Di leukemia cell line the racemic platinum (II) complexes are more active than their meso-analo- 
gues and equiactive with cis-platin. The position of the fluorine atom and the kind of the leaving group do not influence 
the activity. 
RbumC - Synthese des diastCrkoisomi%res 1,2-bis(2-,3- et 4-fluoroph&yl)6thyl&nediamines 4-6, lo-12 g partir de 
m&o 1,2-bis(2-hydroxyphCnyl)&hyl&nediamine et de 2-,3- et 4-fluorobenzaldbhyde par la transposition de diaza-Cope 
et leur transformation en complexes [1,2-bis(2-,3- et 4-fluorophCnyl)6thylkwdi~e]dihaIoplatine (II) (Hal = Cl: 
13-18; Hal = I: 19-24) g I’aide de K,PtH&. A partir des complexes de diiodoplatine (ZZ) (19-24), on obtient des 
composes plus hydrosolubles tels des sulfates de diaquaplatine (ZZ) [I,2-bis(Juoro-2, -3 et 4 phenyl)tthylenediamine] 
(25-30) et des [1,2-bis(4-fluorophenyl) tthylenediamine]dinitratoplatine (ZZ) complexes (31 et 32) par reaction avec 
Ag2S04 et AgN03 respectivement. Dans les cellules en lignees de leucemie P388Dt, les complexes racemiques de platine 
(ZZ) sont plus actifs que leurs analogues meso et aussi actifs que le cis-platine. La position du jluor et la nature du groupe 
partant n’influencent pas l’activite. 
diastereomeric l,%bis(2-,3- and 4-fluorophenyl)ethylenediamines / d&a-Cope-rearrangement / [1,2-bis(2-,3- and 4luoropbenyl)ethylenediamine] 
dihaIopIatinum(I1) complexes / diaqua[l,Zbis(2-,3- and 4-fluorophenyl)ethylenediamine] platinum(II) spits / P388D1 leukemia cell line/structure 
activity-relationship 
Introduction 
Strong antitumor activities of stereoisomeric (1,2-di- 
phenylethylenediamine)platinum (II) complexes have 
been reported [l-5]. Whereas Gulotti et al. [l] and Noji 
et al. [2] found that there is no clear-cut preference for one 
stereoisomer, we generally observed in our studies [3-51 
with stereoisomeric 4-substituted (1,2-diphenylethylene- 
diamine) platinum (II) complexes on several in vitro and 
in vivo tumor models significantly better effects of the 
racemates compared with the meso-forms. Among these 
derivatives [D,L-1 ,2-bis(4-fluorophenyl)ethylenediamine]- 
dichloroplatinum (II) was the most active on the human 
MDA-MB 231 breast cancer cell line and the P 388 leuke- 
mia of the mouse [4]. 
Dichloro( 1,2-diphenylethylenediamine)platinum(II) 
complexes are characterised by extremely low solubilities 
in water. This disadvantage can be overcome by their 
transformation into the better water soluble diaqua- 
(1,2-diphenylethylenediamine)platinum(II) sulfates and 
(1,2-diphenylethylenediamine)dinitratoplatinum(II) com- 
plexes, respectively. 
However, the diaqua complexes are charged species, 
and it is generally accepted that a charged complex will 
exhibit no antitumor activity because ionized compounds 
are unable to diffuse freely across the membrane barrier. 
Nevertheless, in several studies antitumor activity of ionic 
platinum(I1) complexes has been observed [l, 6, 71. Ber- 
nasetti et al. [6] found that potassium tert-butylaminetri- 
chloroplatinate(I1) was active against murine P 388 and 
*Author to whom correspondence should be addressed. 
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L 1210 leukemia models. Gulotti et al. [l], who compared 
a series of C-substituted dichloro(ethylenediamine)plati- 
num(I1) complexes with the analogous diaqua(ethylene- 
diamine)platinum(II) sulfates, reported similar results for 
the nonionic and the ionic complexes. With &(diam- 
mine)diaquaplatinum(II)nitrate and -sulfate, Macquet 
and Butour [7] saw no tumor-inhibiting effect in the L 1210 
leukemia of the mouse. However, a very high toxicity was 
observed which was attributed to the high reactivity of the 
diaqua complex. On the other hand, by replacing the NHs- 
ligands with 1,2-diaminocyclohexane they observed a 
marked antitumor effect and less toxicity. This suggests 
that even charged complexes enter the cell if the diamine 
ligands are lipophilic. However, it cannot be excluded that 
charged complexes are partially transformed into neutral 
species by reaction with Cl- or other nucleophiles in the 
plasma, then entering the tumor cell more quickly. 
The aim of this work was to investigate the influence of: 
(1) the position of the fluorine atom; (2) the configuration 
at Ci and C, of the ethylenediamine moiety; (3) the nature 
of leaving group (Cl-, N03- or HzO) on the antitumor 
activity of diastereomeric [ 1 ,Zbis(fluorophenyl)ethylene- 
diamine]platinum(II) complexes. 
Chemistry 
The (1,2-diphenylethylenediamine)dihaloplatinum(II) 
complexes 13-24 were synthesized by reacting &PtCl, or 
K,PtI, with the corresponding diamines 4-6 and lo-12 in 
water or t-butanol/water solution at pH 5.5-6.5 and a 
temperature of 5@C (Scheme 1, Methods A - 0). The ana- 
lytical and NMR data are listed in Table Ia and Ib. 
HC------CH 
/ \ 
H2N NH2 
4-6 
10-12 
compd. config. R 
4 meso 2-F 
5 neso 3-F 
6 meso 4-F 
10 0, L 2-F 
11 D,L 3-F 
12 D,L 4-F 
Scheme 1. 
R R 
PP Method E 
HC- CH d 
/ \ *g2so4 
H2N\ /NH2 
/pt\ 
I I 
Method F 
2 AgN03 
7 
R R 
PP 
-CH 
i’ \ 
NH2 NH2 
Tp+< 
N03 No3 
-CH 
i’ \ 
H2N 
‘Pt’ 
NH2 
compd. config. R 
25 D,L Z-F SO4 
26 0.L 3-F SO4 
27 0-L 4-F SO4 
28 meso 2-F SO4 
29 meso 3-F SO4 
30 nleso 4-F SO4 
31 0.L 4-F 2N03 
32’ nwso 4-F 2N03 
Scheme 2. 
*This compound was obtained by the reaction of the dichloroplati- 
num(II)-complex with AgN03. 
**X = leaving group. 
R R 
Method A,B:K2PtC14 
Method C,D:K2Pt14 
q @ 
HC. Cji 
/ \ 
H2N\ //HZ 
/P+\ 
Hal Hal 
13-24 
compd. config. R Hal 
13/19 D,L 2-F Cl/I 
14/20 D,L 3-F Cl/I 
15/21 D,L 4-F Cl/I 
16/22 meso 2-F Cl/I 
17/23 meso 3-F Cl/I 
18/24 meso 4-F Cl/I 
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Table Ia. Dihalo(l,2-diphenylethylenediamine)platinum(II) complexes. 
Compd. Substituent Yield Formula Halogen C % H % N % 
ligand 
@) Calcd. Found Calcd. Found Calcd. Found 
D,L-13 
D,L-14 
D,L-15 
meso- 
meso- 
meso- 
D,L-19 
D,L-20 
D,L-21 
meso- 
meso- 
meso- 
2-F 
3-F 
4-F 
2-F 
3-F 
4-F 
2-F 
3-F 
4-F 
2-F 
3-F 
4-F 
W-WzWV’t ,, Cl ,, 
n 
,1 
n 
, ,  
I ,I 
,> 
11 
,, 
>, 
32.70 n 
24.12 
33.09 
32.87 
32.83 
32.73 
32.84 
32.85 
24.48 
24.18 
24.14 
24.36 
24.34 
24.21 
2.74 1, 
1, 
n 
9, 
7, 
2.02 >, 
,, 
1, 
n 
,1 
2.80 5.45 5.46 
2.77 ” 5.38 
2.71 ” 5.42 
2.85 ” 5.57 
2.84 ” 5.23 
2.83 ” 5.48 
2.15 4.02 4.12 
2.05 ” 4.05 
2.05 ” 3.91 
2.11 ” 3.90 
2.07 ” 3.90 
2.28 ” 3.80 
Table Ih. rH NMR data for dihalo(l,2-diphenylethylenediamine)platinum(II) complexes. 
Comp. Substituent Halogen Arom. H CH NH 
D,L-13 
D,L-14 
D,L-15 4-F 
meso- 
meso- 
meso- 
2-F 
3-F 
4-F 
D,L-19 2-F 
D,L-20 3-F 
D,L-21 4-F 
meso- 
meso- 
meso- 
2-F 
3-F 
4-F 
I n 
,’ 
6.94-7.97 (m,8H) 
6.99-7.64 (m,8H) 
7.05-7.12 (t,4H; 3.5-Pos.) 
7,82-7&i (q,4H; 2.6-Pos.) 
6.99-8.48 (m,8H) 
7.03-7.61 (m,8H) 
7.07-7.14 t,4H; 3.5-Pos.) 
7.63-7.69 I q,4H; 2.6Pos.) 
6.94-8.08 
7.01-7.53 
t m,8H) 
m,8H) 
7.02-7.24 (t,4H; 3.5-Pos.) 
7.58-7.63 (q,4H; 2.6-Pos.) 
6.99-8.41 m,8H) 
7.01-7.58 t m,8H) 
7.07-7.14 (t,4H; 3.5-Pos.) 
7.63-7.69 (q,4H; 2.6-Pos.) 
4.69 (s,2H) 
5.10 (s,2H) 
5.44 (s,2H) 
4.75 (s,2H) 
4.65 (s,2H) 
4.67 (s,2H) 
4.75 (s,2H) 
t*g yq 
. s, 
4.72 (s,2H) 
4.51 (s,2H) 
4.43 (s,2H) 
5.68(mb*,2H) 
5.98 (mb,2H) 
6.06 (mb,2H) 
5.73 (ms,2H) 
5.82 (mb,2H) 
5.76 (mb,2H) 
5.50 (mb,2H) 
5.58 (mb,2H) 
5.50 (mb,2H) 
5.61 (mb,2H) 
5.64 (mb,2H) 
5.76 (mb,2H) 
6.45 (mb,2H) 
6.57 (mb,2H) 
6.62 (mb,2H) 
6.38 (mb,2H) 
6.29 (mb,2H) 
6.26 (mb,2H) 
6.40 6.32 (mb,2H 1 ( b,2  
6.23 (mb,2H) 
6.29 (mb,2H) 
6.15 (mb,2H) 
6.26 (mb,2H) 
250 MHz, G(ppm), solvent: DMF-dT, standard: TMSINT 
*b = broad. 
Table II. Diaqua(l,2-diphenylethylenediamine)platinum(II) complexes and (1,2-diphenylethylenediamine)dinitratoplatinum(II) complexes. 
Compd. Substituent Yield Formula Leaving C% H% N% 
groups 
W) Calcd. Found Calcd. Found Calcd. Found 
D,L-25 2-F ;: C,4H,4FzNz04PtS.2H20 sod- 29.23 29.67 3.15 3.17 4.87 4.48 
D,L-26 3-F 9, I, 7. 29.52 77 3.22 ” 4.85 
D,L-27 4-F 
meso- 2-F E 
0 1, n 29.20 >1 3.29 ” 4.63 
,> 71 n 29.32 >, 3.12 ” 4.84 
meso- 3-F 81 ,> ,, ,I 28.98 ,1 3.17 ” 4.97 
meso- 4-F 1, 9, 7, 29.54 ,1 3.15 4.87 
D,L-31 4-F 
;i 
W-WzWW’t 2 NOs- 29.64 30.04 2.49 2.76 9’;s 9.68 
meso-32* 4-F 17 >, I, n 30.07 1, 2.89 ” 9.68 
*This compound was obtained by the reaction of the dichloroplatinum(I1) complex instead of the diiodoplatinum(I1) complex with AgNOs. The 
lower reactivity of the dichloroplatinum(I1) complex is responsible for the small yield. 
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The diaqua( 1,2-diphenylethylenediamine)platinum(II) 
sulfates 25-30 and (1,2-diphenylethylediamine)dinitrato- 
platinum(I1) complexes 31-32 are obtained by the reac- 
tion of the (1,2-diphenylethylenediamine)diiodoplati- 
num(I1) compounds 19-24 with Ag2S04 or AgN03 in 
water (Scheme 2, Method E,F, Table II). 
The meso-1,2-diphenylethylenediamines 4-6 were syn- 
thesized by the [3.3] sigmatropic diaza-cope-rearrange- 
ment reaction as described by VGgtle and Goldschmitt [8] 
(Scheme 3). At a temperature below 12OoC meso-1,2- 
bis(2-hydroxyphenyl)ethylenediamine and the respective 
aldehyde react to form quantitatively the corresponding 
meso-N,N’-disalicylidene-diphenylethylenediamines l-3 
HO HC- CH OH + 2 
/ \ 
2 NH2 
f&j 
HO HC- CH OH 
/ \ 
N 
AT/~o'c 
cl . N 
\” 
@ 
R 
/ 
HC 
@ 
R 
. ( )  
Method H 
R 
4 
R 
Method G 
CHO 
HC OH 
Ho //"" \ 
N 
\ r 
-iH 4 @ 
OH 
CHO 
IWSO 4-6 (R = Z-F, 3-F or 4-F resp.) 
Scheme 3. 
Table III. Mao-N, N’-disalicylidene-1,2-diphenylethylenediamines. 
(Method G, Table III). Subsequent acidic hydrolysis 
yielded the meso-1,2-diphenylethylenediamines 4-6 
(Method H). The D,L-1,2-diphenylethylenediamines 
lo-12 were synthesized by the meso-o,L-stereoisomerisa- 
tion of the meso-N,N’-dibenzylidene-1,2-diphenylethyle- 
nediamines 7-9 (Table IV), which are identically substi- 
tuted in all 4 phenyl rings, at a temperature >200% and 
followed by a sulfuric acid hydrolysis (Scheme 4, Method 
K). The diastereomers were separated by fractional crys- 
tallisation of the dihydrosulfates or the free bases (see 
experimental section, Methods K, and Kb). The analytical 
data of the 1,2-diphekvlethvlenediamines are listed in 
Table V. - - - 
CHO 
RESO 4-6 
R R R 
N 
\ 
CH 
@ 
R 
7-9 
H+/H20 
Method K 
Scheme 4. 
Method I 
R 
@ 
CH 
\ 
HC' tk'H 
H2N' i'4H2 
meso 4-6 and D,L lo-12 (R = 2-F. 3-F or 4-F resp.) 
Compd. Substituent mp PC) Yield (%) ‘H NMR data, 60 MHz, standard: TMSm 
solvent: CDC& 
H-benzyl. H-arom. N=C-H 
: 
3 
2-F 
3-F 
4-F 
215-21s 85 
213-214 73 
178-180 72 
a 1H NMR spectrum was not recorded 
4.73 (s,2H) 6.73-7.38 (mJ6H) 
4.63 (s,2H) 6.62-7.44 (m,16H) 
8.11 (s,2H) 
8.10 (s,2H) 
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Table IV. Meso-N,N’-dibenzylidene-l,2-diphenylethylenediamines. 
Compd. Substituent mp PC) Yield (%) 1H NMR data, 60 MHz, standard: TMStNr 
solvent:CDCl, 
H benzyl. H arom. N=C-H 
I 
9 
2-F 186-188 
3-F 148-149 
4-F 166-167 
a tH NMR spectrum was not recorded 
4.64 (s,2H) 6.79-7.63 (m,16H) 
4.62 (s,2H) 6.72-7.84 (m,16H) 
7.91 (s,2H) 
7.93 (s,2H) 
Table Va. 1,2-diphenylethylenediamines. 
Compd. Substituent Yield (%) mp PC) C H N 
Calcd. Found Calcd. Found Calcd. Found 
meso- 2-F 74 91-92 67.72 67.72 5.68 5.70 11.28 11.28 
meso- 3-F 92 60-61 1, 67.63 ” 5.71 1, 11.03 
meso- 4-F 44 99-101 ,> 67.74 ” 5.75 11 11.27 
ILL-10*2HCl 2-F 34 226-228 52.35 52.31 5.02 4.97 8.72 8.67 
o;~-11*2HCI 3-F 22 237-238 >, 52.23 ” 5.16 >, 8.56 
D,L-U*~HC~ 4-F 66 237-238 I, 52.37 ” 4.94 3, 8.65 
Table Vb. rH NMR data of the 1,2-diphenylethylenediamines. 
Compd. Substituent H arom. H benzyl. N-H 
meso- 
meso- 
meso- 
O,L-10 
D,L-11 
!J,L-12 
2-F 6.82-7.68 (m,8H) 4.48 (s,2H) 1.50 (s,4H) 
3-F 6.74-7.74 (m,8H) 3.99 
4-F 6.83-7.46 (m,8H) 
(s,2H) 1.73 (s,4H) 
3.98 (s,2H) 1.39 (s,4H) 
2-F 6.76-7.60 (m,8H) 4.47 (s,2H) 1.73 (s,4H) 
3-F 6.68-7.34 (m,8H) 4.02 (s,2H) 1.59 (s,4H) 
4-F 6.69-7.28 (m,8H) 3.97 (s,2H) 1.57 (s,4H) 
60 MHz, standard: TMSINT, solvent: CDCl,. 
1H NMR spectroscopy 
The classification of the new 1,2-diphenylethylenediami- 
nes 4-6 and lo-12 as the D,L- or meso-form results from 
the stereoselective course of the diaza-cope-rearrange- 
ment reaction. The aromatic protons of the D,L com- 
pounds are shifted upfield relative to the respective pro- 
tons of the meso-compounds. By the formation of the 
dichloroplatinum(I1) complexes all resonances of the 1,2- 
diphenylethylenediamines, particularly those of the amine 
and benzylic protons are shifted to lower field. Since the 
complexation blocks rotation around the C-N axis, both 
N-bound protons become diastereotopic owing to the 
neighborhood of the asymmetric C-atoms. This leads to 
the appearance of separate signals for the axially and for 
the equatorially orientated N-H atoms. Due to a coupling 
between NH2, benzylic CH and 19sPt, the NH and CH 
signals are broadened. The distinction of the 2 NH signals 
from the CH (benzylic) signals was performed using the 
4-fluorosubstituted complex ~,~-15 as a model. The lack 
of free electron pairs at the N of the complex prevents an 
exchange of the N-standing H atoms by deuterium. There- 
fore the H-D exchange was effected with the free ligand, 
which was then transformed into the dichloroplatinum(I1) 
complex. The NH signals appeared downfield from the 
CH signal. 
The resonances of the amine and benzylic protons of the 
dichloroplatinum(I1) compounds are shifted downfield 
compared with the diiodoplatinum(I1) complexes. Eval- 
uable 1H NMR spectra of the diaquaplatinum(I1) and 
nitratoplatinum(I1) complexes could not be obtained in 
available solvents like trifluoroacetic acid, DMF-d7 or 
CDsOD because of the insufficient solubility or reactions 
with the solvent. Due to the formation of various coordi- 
nation species the resonance signals are broadened. 
The solubility of these diaquaplatinum(I1) complexes in 
water is sufficient to get clear solutions for the cell culture 
and animal experiments but the solubility is too low for 1H 
NMR spectroscopy. 
IR spectroscopy 
The IR spectra (KBr) of the dichloroplatinum(I1) com- 
plexes (13-18) reveal that the absorption band for the 
N-H stretching vibration is shifted by = 100 cm-i to 
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Table VI. Dihalo(l,Z-diphenylethylenediamine)platinum(II) complexes. 
Compd Substituent Formula Halogen ligand vN-H vPt-Cl 
D,L-W 
D,L-14 
D,L-15 
meso- 
meso- 
meso- 
D,L-19 
D,L-20 
D,L-21 
meso- 
meso- 
meso- 
iz 
4F 
2F 
3F 
4F 
2F 
3F 
z 
3F 
4F 
, ,  
11 
11 
1, 
, ,  
3270 s, 3200 s 320 m 7’ ,, 1, 
3280 m, ” ,, 
3260 m, 3210 s 71 
7, 1, 7, 
‘, 7, 
3240 s, 3liO m, 3, 
3230 m, 32; m 
’ 3250 s, 3200 s, 3160 s 
3265 s, 3220 s, 3195 s 
3260 s, 3200 m, 3145 m 
lower wave numbers (3200-3280 cm-l) upon formation of 
the platinum-nitrogen bonds. The absorption band in the 
far infrared close to 320 cm-l indicates a cis-PtCl, struct- 
ure [9] and is absent in the diiodoplatinum(I1) complexes 
(Table VI). 
The sulfatoplatinum(I1) complexes (KBr) (25-30) 
show a strong absorption band at 1130 cm-l and a weaker 
band at 620 cm-l, which are indicative for a ionic sulfate 
residue, and a broad absorption band for the OH 
stretching vibration at 3440 cm-t. On the basis of these 
results and of elemental analyses we suppose a structure 
in which 2 Hz0 molecules are bound to the platinum atom 
with sulfate as counter ion. In case of coordination to pla- 
tinum the high Td symmetry of the sulfate ion is lowered 
resulting in further absorption bands [lo]. Additional 
weak bands at 900-1000 cm-l and at 1180-1220 cm-l in 
the spectra of 25-30 suggest a contamination with other 
types of coordination complexes. 
The IR spectra of the nitratoplatinum(I1) complexes 
(KBr) (31 and 32) show, when compared with the corres- 
ponding diiodoplatinum(I1) complexes 4 new absorption 
bands: 1500 cm-l (m), 1390 cm-l (s) and 1270 cm-l (m) 
and 990 cm-1 (m). The absorption bands at 1500 cm-l and 
1270 cm-l originate from an asymmetric and a symmetric 
N-O2 stretching vibration, while the N-O stretching vibra- 
tion produces an absorption band at 990 cm-l [ll]. The 
absorption band at 1390 cm-l (NO* asym. str.) can be atti- 
buted to the free nitrate ion [12]. 
However, this band is not present when the spectrum is 
taken as a Nujol mull. The other absorptions remain 
unchanged. This phenomenon can be explained by a reac- 
tion of the nitratoplatinum(I1) complex with the KBr; a 
bromoplatinum(I1) complex is formed and free nitrate is 
liberated. From this observation and the fact that nitrato- 
platinum(I1) complexes (31 and 32) contain no additional 
Hz0 molecules it can be concluded that 2 nitrate ions are 
coordinated unidentate at one platinum atom. For the sul- 
fatoplatinum(I1) complexes the IR spectra were identical 
in KBr and Nujol. 
Pharmacological results 
The experiments on the P388Dl leukemia cell line show 
that identically configurated [1,2-bis(fluorophenyl)ethyl- 
enediamine]dichloroplatinum(II) complexes (13-18) and 
their diaquaplatinum(I1) sulfates and dinitratoplati- 
num(I1) complexes (25-32) are comparably active in inhi- 
biting cell proliferation and 3H-thymidine incorporation 
regardless of the position of the fluorine atoms. Generally 
compared with the R,S-compounds a stronger activity of 
the R, R / S, S diastereomers was observed, the latter com- 
pounds being equiactive with cis-platin (Table VII). 
Experimental protocols 
Syntheses 
Method A: Dichloro-o,L-(l,2-diphenylethylenediamine)platinum(II) 
(D, ~-1.3 to D. L-IS; Table Ia. Zb) 
&-1,2-Diphenylkthylenedjar&e- 2HCl(l mmol) is dissolved in 10 ml 
water and a solution of K2PtC14 (1 mmol) in 8 mi water is added slowly. 
The pH is adjusted to 5.5-6.5 with 1N NaOH. The solution is stirred at 
5WC for 24-30 h in the dark. During this time the pH is adjusted several 
times until pH stabilizes. The yellow precipitate is collected by suction 
filtration using a no. 3 fritted glass filter, washed with 1N HCl, water and 
dried in vacuum over silica gel / CaCl*. 
Method B: Dichloro-meso-(1,2-diphenylethylenediamine)pla~inum(Ii) 
(meso- to meso-18; Table la, Zb) 
Meso-1,2-diphenylethylenediamine (1 mmol) is suspended in lo- 15 ml 
water and dissolved by heating (ca. 5OoC) and addition of 1 N HCl. The 
solution is diluted with 25 ml t-butanol. The subsequent reaction is 
conducted in analogy to Method A. 
Method C: ~,~-(1,2-Diphenylethylenediamine)diiodop~atinum(II) (D, L- 
19 to D, ~-21; Table la, Ib) 
K,PtCl, (1 mmol1. D.L-1.2-diohenvlethvlenediamine-2 HCl (1 mm011 
aid KIT@0 mmolj ‘are each d&o&d in’10 ml water. The KI sblution is 
added to the KZPtC14 solution. The mixture is stirred for 30 min at WC. 
The color changes from red to black. This mixture is added slowly to the 
solution of the ligand and the complex precipitates immediately. The pH 
is adjusted once with 1 N NaOH to 5.5-6.5. After stirring for 30 min at 
5W in the dark the precipitate is collected by suction filtration using a 
no. 3 fritted glass filter, washed with water and dried in vacuum over 
silica gel / CaC12. 
Method D: mao-(1,2-Diphenyle~hylenediamine)diidop&inum(Ii) (meso- 
22 to meso-24; Table la, Ib) 
Meso-1,2-diphenylethylenediamine (1 mmol) is suspended in lo-15 ml 
water and dissolved by heating (ca. SOOC) and addition of 1 N HCl. The 
solution is diluted with 25 ml-t-butanol. The subsequent reaction is car- 
ried out as in Method C. 
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Table VII. Effect of diastereomeric [1,2-bis(fluorophenyl)ethylenediamine]dichlorop~atinum(II) complexes and diaqua[l,2-bis(fluorophenyl)ethyl- 
enediamine]platinum(II) sulfates and [1,2-bis(4-fluorophenyl)ethylenediamine]dinitratoplatinum(II) complexes on JH-thymidine incorporation and 
cell proliferation of P388Di leukemia cells, 48 h drug incubation. 
Compound (No.) Cell No. 
%T/Cat 
l.lO-6M 
EDso* 
(Ml 
3H-Thymidine incorporation 
%T/C at EDso 
l.lO-6M Of) 
meso-2F-PtSO‘, (28) 
meso-3F-PtSOd 29) 
1 meso-4F-PtSO1 30) 
meso-4F-Pt(NO& (32) 
93 2.6.10-e 92 2.6.10-h 
77 1.8.10-G 77 2.3.10-h 
88 3.8.10-h 84 4.0.10-e 
86 3.8.W6 92 3.4.10-e 
meso-2F-PtClr (16) 69 2.3.10-h 
meso-3F-PtClr (17) 83 4.1.10-e 
meso-4F-PtClr (18) 90 2.6.10-e 
75 
;: 
2.2.10-G 
4.8.10-e 
3.4.10-G 
o,L-2F-PtSO, (25) 
o,L-3F-PtSO, (26) 
o,L-4F-PtSO, (27) 
2 
31 
4.3.10-7 
5.1.10-7 
5.4.10-7 
3.510-7 
6.5.10-7 
7.2.10-7 
m.-4F-Pt(No3)2 (31) 4.6.10-r 5.9.10-7 
o,L-2F-Ptc12 (13) 
o,r.-SF-PtC& (14) 
o,L-4F-Ptc12 (ti) 
2.0.10-7 
4.4.10-7 
4.3-10-7 
8 
:i 
4.8.10-T 
4.9.10-7 
5.5.10-7 
Cis-platin 29 4.8.W7 19 4.5.10-7 
*ED,, =the effective dose, which decreases the tumor growth by 50 %. 
Method E: Diaqua-(1,2-diphenylethylenediamine)platinum(II) sulfate 
(D, ~-25 to D, ~-27, meso- to meso-30; Table II) 
Diiodoplatinum(I1) complex (1 mmol) and Ag,S04 (0.95 mmol) are sus- 
pended in 150 ml water. The mixture is stirred for 24 h at 5WC in the 
dark. The precipitated AgI is filtered off using a no. 4 fritted glass filter. 
The filtrate is freeze-dried. An excess of water can be removed by drying 
in vacuum over silica gel / CaCl,. 
Method F: (1,2-diphenylethylenediamine)dinitratoplatinum(H) (D, ~-31 
and meso-32; Table II) 
The reaction is conducted in the same manner as described in method 
E, but instead of 0.95 mmol Ag2S0, 1.90 mmol AgNOs are used. 
Method G: meso-N,N’-disalicylu&xe-1,2diphenylethylene~ (meso- 
1 to meso-3; Table III) 
Meso-1,2-bis(2-hydroxyphenyl)ethylenediamine (0.1 mol) and the rela- 
ted isomeric fluorobenzaldehyde (0.2 mol) are heated under reflux in 100 
ml acetonitrile for 4 h. The solution is concentrated until the product 
begins to precipitate. After standing in the refrigerator for 1 h the preci- 
pitate is collected in a Buchner funnel, washed with small amounts of 
ice-cold acetonitrile and dried over P205. 
Method H: meso-1,2-diphenylethylenediamine (meso- to meso-6; 
Table Va and Vb} 
Meso-N,N’-disalicylidene-l,2-diphenylethylenedamine (30 g) is hydro- 
lyzed with 300 ml 5 N HZS04 and the salicylic aldehyde formed is remo- 
ved by steam distillation. The hot solution is filtered and made alkaline 
with 20% NaOH under vigorous stirring until the free base is precipita- 
ted completely. The diamine is extracted with CHrCI, and the organic 
layer dried over MgSO+ The solvent is removed in vacuum and the resi- . due is dried over Pro,. 
Method I: meso-N,N’-dibazylidene-1,2-diphenylethyl (meso 
7 to meso-?; Table IV) 
Meso-1,2-dtphenylethylenediamine (0.1 mol) and the aldehyde (0.2 
mol) are heated under reflux in 100 ml acetonitrile for 5 h. The mixture 
is concentrated until the product begins to precipitate. After standing in 
the refrigerator for 1 h the product is collected in a Buchner funnel, 
washed with small amounts of ice-cold acetonitrile and dried over Pros. 
Method K: D, t.-1,2-diphenylethylenediamine (D, L-IO to D, ~42; Table Va 
and Vb) 
Meso-N,Nf-dibenzylidene-l,2-diphenylethylenediamine (25 mmol) is 
melted under vigorous stirring. After 10 min the liquid is allowed to cool. 
The glassy mass is hydrolized with 150 ml 5 N H2S04 and the salicylic 
aldehyde formed is removed by steam distillation. The hot solution is 
filtered. 
Isolation method K,. The sulfate salt of D,L-1,2-diphenylethylenedia- 
mine crystallizes at room temperature. The salt is collected in a Buchner 
funnel. In a separatory funnel the sulfate salt is treated with 1 N NaOH, 
extracted with CHZCIZ and the organic layer is dried over MgS04. After 
removal of the solvent the free base is obtained as an oil (D,L-12) or as 
crystals (D,L-10: mp: 79-810C). To gain the meso-l,Zdiphenylethyl- 
enediamine the mother liquor is treated as described in Method H. 
Isolation method Kb. The diastereomeric 1,2-diphenylethylenediamines 
are precipitated with 20% NaOH, extracted with CH,Clr and the organic 
layer is dried over MgS04. After removal of the solvent the diastereo- 
mers are separated by fractional crystalhsation in ether / petrolether 5: 1. 
The meso-1,2-diphenylethylenediamine crystallizes and the D,L isomer 
remains in the mother liquor. The meso-compound is separated by suc- 
tion filtration using a fritted glass filter, The o,r,-compound is received 
from the filtrate by removing the solvent.(o,L-11: oil) The transforma- 
tion of the 1,2-diphenylethylenediamines into their dihydrochlorides 
was achieved by dissolving in small amount of methanol and addition of 
a saturated solution of anhydrous HCl in Et,O. The crystalline precipi- 
tate is isolated by suction filtration using a fritted glass filter. 
Biological methods 
P388Dt leukemia cell structure experiments: standard conditions. The 
P388Di cells (ATCC CCL 46) were grown in static suspension culture 
in RPM1 1640 medium (Gibco) supplemented with 10% heat-inactivated 
horse serum (Boehringer), 10 mM HEPES buffer (Biochrom), 2 mM 
glutamine (Biochrom) and NaHCO, (0.85 g/l) in a H,O saturated 
atmosphere containing 5% CO1 at 37<. Stock cultures were rown in 
75 cm* culture flasks (Falcon). The diaqua and nitratoplatinum II) com- f 
plexes were dissolved in bidistilled water or methanol, the dichloroplati- 
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num(I1) complexes in DMF. The test compounds were added as 500- or 
IOOO-fold concentrated stock solutions. 
Determination of EDSo. 2 ml of cell suspension (7-8104 cells/ml) were 
placed in glass centrifuge tubes sealed with aluminium caps and incuba- 
ted under standard conditions. After 4 h incubation cells were counted 
with a Coulter Counter (Coulter Electronics Ltd.) and the test com- 
pounds were added. 2 h prior to the end of the experiment the cells were 
labeled with 0.3 &i [sH]thymidine (40-60 Ci/mmol, New England 
Nuclear) oer tube. After 48 h 0.5 ml of culture were used to determine 
the cell’number, the remaining portion was centrifuged and washed 
twice with ice-cold PBS. (Phosphate buffered saline: NaCl (8g), KC1 (0.2 
g), Na2P04 x 2 Ha0 (1.0 g), NaH2P04 x 1H20 (0.15 g) and KH2P04 (0.2 
a) in 1 1 of H,O. The pellet was resuspended in 1 ml water and the cells 
Zere destroyed by so&cation using a’Branson sonifier; 4 ml 10% TCA 
were added and the precipitate was filtered with 0.45 pm filter (Sarto- 
rius). The sH-thymidine incorporation was determined in 10 ml 
Quickszint 212 (Zinsser Analytik) in a Beckmann LS 1801 liquid scintil- 
lation counter. Percentage T/C-values based on cell number were cal- 
culated according to [(T-Z) /(C-Z)].100 (T: cell number of treated cell 
culture at the end of incubation, C: cell number of untreated cell culture 
at the end of incubation, Z: cell number at the beginning of incubation). 
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